Nasus Pharma Announces Positive Clinical Results of Recent Phase 2 Study With FMXIN002 Intranasal Epinephrine
Rapid and higher epinephrine absorption- for potentially quicker rescue of patients in anaphylactic shock
Source: channel3000.com
Nasus Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasus Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasus Pharma Today - Breaking & Trending Today
Nasus Pharma Announces Publication of Positive Clinical Results with Epinephrine Intranase Powder Aerosol
(Information sent by the signatory company)
Source: d1softballnews.com
Nasus Pharma Announces Publication Of Its Positive Clinical Results With FMXIN002 Intranasal Powder Epinephrine Spray In The Journal Of Allergy And Clinical Immunology In Practice
/PRNewswire/ -- Nasus Pharma Ltd a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal (PBI) product portfolio,...
Source: prnewswire.com
Global Naloxone Spray Market Drivers, Trends And Restraints For 2022-2031
The Business Research Company’s Naloxone Spray Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
Source: einnews.com
Allergic Rhinitis Pipeline To Progress With Novel and Emerging Drugs, Analyzes DelveInsight
Allergic Rhinitis Pipeline involves 32+ key companies continuously working towards developing 32+ Allergic Rhinitis tre...
Source: sina.com.hk